Virpax Pharmaceuticals
Stock Forecast, Prediction & Price Target

Virpax Pharmaceuticals Financial Estimates

Virpax Pharmaceuticals Revenue Estimates

Virpax Pharmaceuticals EBITDA Estimates

Virpax Pharmaceuticals Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $56.59M
Low: $56.59M
High: $56.59M
avg. 0%
Avg: $97.38M
Low: $97.38M
High: $97.38M
avg. 72.08%
Net Income
 
% change YoY
$-12.14M
 
N/A
$-21.45M
 
-76.61%
$-15.18M
 
29.20%
Avg: $-15.71M
Low: $-2.65M
High: $-2.65M
avg. -3.43%
Avg: $-17.59M
Low: $-1.69M
High: $-1.69M
avg. -11.98%
Avg: $1.42M
Low: $1.42M
High: $1.42M
avg. 108.12%
Avg: $4.42M
Low: $4.42M
High: $4.42M
avg. 209.83%
EBITDA
 
% change YoY
$-11.96M
 
N/A
$-21.65M
 
-80.97%
$-15.18M
 
29.84%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$10.37
 
N/A
-$18.32
 
-76.66%
-$12.97
 
29.20%
Avg: -$2.27
Low: -$2.27
High: -$2.27
avg. 82.49%
Avg: -$1.45
Low: -$1.45
High: -$1.45
avg. 36.12%
Avg: $1.22
Low: $1.22
High: $1.22
avg. 184.13%
Avg: $3.78
Low: $3.78
High: $3.78
avg. 209.83%
Operating Expenses
 
% change YoY
$12.02M
 
N/A
$21.84M
 
81.65%
$15.68M
 
-28.17%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Virpax Pharmaceuticals stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 75.63% in 2025-2028.

We have gathered data from 1 analysts. Their low estimate is -2.65M, average is -15.71M and high is -2.65M.

What is Virpax Pharmaceuticals stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 18.02% in 2025-2028.

We have gathered data from 1 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Virpax Pharmaceuticals stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 128.14% in 2025-2028.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$2.27, average is -$2.27 and high is $-2.27.